COVID-19 clinical trials to develop treatments will get answers faster if people collaborate, Susan Ellenberg, PhD, commented. “As some treatments show evidence of benefit, we will be moving to studies of drug combinations, and these trials will require larger sample sizes — meaning, in most cases, multicenter trials.”